An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care

drug protocol number
version 8
drug sponsor
GDRS (MOH)
drug study
Hydroxychloroquine sulphate
drug trial site
QCH
drug status
Ongoing
drug phase